Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
about
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast CancerSpectral analysis of naturally occurring methylxanthines (theophylline, theobromine and caffeine) binding with DNACisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer.Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countriesNovel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancerMolecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer PatientsMitochondria and familial predisposition to breast cancer.Mutation Screening of BRCA Genes in 10 Iranian Males with Breast Cancer.Male breast cancer in a multi-gene panel testing cohort: insights and unexpected resultsClinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review.BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samplesA comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients.Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalencRecurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal.Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.The role of BRCA status on prognosis in patients with triple-negative breast cancer.The role of Rak in the regulation of stability and function of BRCA1.Actionable secondary findings from whole-genome sequencing of 954 East Asians.Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels.Prevalence and Spectrum of BRCA1/2 Germline Mutations in Women with Breast Cancer in China Based on Next-Generation Sequencing.Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.
P2860
Q27023165-B326FF7C-468B-4E4A-BE0C-D34C18291EFFQ28484252-D8EF22E9-0C07-4875-B861-A6ED2DBDA909Q33415281-848F051F-EEB9-419B-BC7A-F0A5FF7E1684Q35558112-21990A0A-582B-4D5C-9193-EB3237370B77Q35695425-4E97B56C-A577-41ED-826F-E60AE3AA21D6Q35916576-F2302BA0-913D-4C34-98F6-32F5B27AF4BDQ35928897-23A77692-ECC0-436A-B00F-6787F25D6B1FQ36039509-097709B7-6801-45E2-A416-BCC3F55E5D20Q36877040-FF6FF48F-2B17-4E21-B7D2-73E627873DBBQ37099612-092AF7D7-E88B-408B-B7BA-CFFAC4BCFE28Q37590600-2D1C83E1-1214-4A9C-A09B-AAC3971B8E67Q38573701-F1FA4924-3B1B-4990-B61E-37E65DBC8346Q38972917-54C88D41-18D2-4CC4-9B13-A5C39B174613Q39395816-18E77CA1-0743-43C9-BE34-439F4C57F024Q40292155-70601831-D88C-4C81-B49A-E7A6F00AFA30Q42121714-6EC7764C-A69A-4299-A296-A8BDCA3E009FQ42181679-CCCF5133-9B26-4FEB-B3FE-F87BD2C7FE22Q42367527-686782E5-5B60-40BD-A633-312B7A9250D3Q42377409-4FEC7F94-24D1-463A-AF74-BAB556526859Q42511786-53710F5F-CD4F-4281-B4C0-A1DEA1B154BAQ44226465-399B7918-410D-415E-9136-A2EA4047F304Q44717730-A3EC6FFB-420C-438F-9191-2461B9BC2FCFQ44746809-E10720D2-CA8A-459C-91F7-131CC3CA7393Q45870377-829DB19A-BCB0-49A3-A3A7-52D3BB63B475Q46104940-EEA8B36A-9007-45F1-8B33-413B300DB086Q47097677-AA08BD50-CF37-446F-8D8E-676BDC184999Q47112583-4465AA5C-E268-4940-B62D-06412732DA87Q47184079-49621047-EF93-4ED5-B47C-E53294035075Q47586106-EA0CCED7-A3B9-4080-9785-F2614E27A397Q50300704-11A5043D-69C8-42EA-B708-AD103578AC3CQ52571638-D130F4A8-3961-4027-B560-A2A1AD30B482Q55389174-9D467435-3A01-48FD-9B13-651737D8D720
P2860
Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@ast
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@en
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@nl
type
label
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@ast
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@en
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@nl
prefLabel
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@ast
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@en
Identification of BRCA1/2 foun ...... solution DNA melting analysis.
@nl
P2093
P2860
P50
P1433
P1476
Identification of BRCA1/2 foun ...... esolution DNA melting analysis
@en
P2093
Allison W Kurian
Chris Lei Po Wong
Dee W West
Edmond Siu Kwan Ma
Fian Bic Fai Law
Hong Nei Wong
P2860
P304
P356
10.1371/JOURNAL.PONE.0043994
P407
P577
2012-09-07T00:00:00Z